|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4745 | (2006.01) |
| A61K 31/409 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) |
| (11) | Number of the document | 1830876 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05855956.8 |
| Date of filing the European patent application | 2005-12-30 | |
| (97) | Date of publication of the European application | 2007-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-08 |
| (46) | Date of publication of the claims translation | 2015-08-25 |
| (86) | Number | PCT/US2005/047467 |
| Date | 2005-12-30 |
| (87) | Number | WO 2006/071997 |
| Date | 2006-07-06 |
| (30) | Number | Date | Country code |
| 640491 P | 2004-12-30 | US |
| (72) |
BENNINGHOFF, Bernd, DE
HENGGE, Ulrich, R, DE
|
| (73) |
Meda AB,
Pipers väg 2A Box 906, 170 09 Solna,
SE
|
| (74) |
Tatjana STERLINA,
UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius,
LT
|
| (54) | Imikvimodo panaudojimas iš krūties vėžinio naviko kilusių odos metastazių gydymui |
| USE OF IMIQUIMOD FOR THE TREATMENT OF CUTANEOUS METASTASES DERIVED FROM A BREAST CANCER TUMOR |
| Payment date | Validity (years) | Amount | |
| 2020-12-07 | 16 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-12-30 |